| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0047 | 0.9 |